TCL Archive OMB Revisions Would Kill 16 Center core Grants, Ban New Ones, Slash Noncompeting Funds 10 Percent April 15, 1983
TCL Archive Perjeta, Herceptin & Docetaxel Combination Extended Survival in HER2-Positive Disease December 28, 2012